(Total Views: 668)
Posted On: 06/09/2020 9:41:29 AM
Post# of 154186
Re: Rubraquercus #37173
The automated facility was previously owned by AstraZeneca and is well designed for high-volume commercial production, AGC noted. It contains two 20,000-liter stainless steel mammalian cell bioreactors with room for four additional bioreactors and has more than twenty acres for future expansion.
AGC plants to run full-scale operations at the new facility by April 2021. It will help the company advance a higher ratio of late-phase and commercial products and support a wider range of commercial demand, the company noted.
In addition, AGC will complete facility expansion projects in Seattle, Denmark, and Japan this year and in early 2021.
https://www.scienceboard.net/index.aspx?sec=s...ItemID=840
AGC plants to run full-scale operations at the new facility by April 2021. It will help the company advance a higher ratio of late-phase and commercial products and support a wider range of commercial demand, the company noted.
In addition, AGC will complete facility expansion projects in Seattle, Denmark, and Japan this year and in early 2021.
https://www.scienceboard.net/index.aspx?sec=s...ItemID=840
(0)
(0)
